JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 17.8% in June

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 447,000 shares, a drop of 17.8% from the May 31st total of 544,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS:JCRRF remained flat at $5.22 on Tuesday. The business’s fifty day moving average is $5.22 and its two-hundred day moving average is $6.69. JCR Pharmaceuticals has a 52 week low of $5.22 and a 52 week high of $6.20.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.